WallStreetZenWallStreetZen

NASDAQ: KYTX
Kyverna Therapeutics Inc Stock Ownership - Who owns Kyverna Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Kyverna Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Karen Marie WalkerChief Technology Officer2024-06-069,636$4.42
$42.59kBuy
Ryan Alexander JonesChief Financial Officer2024-05-287,146$0.73
$5.22kBuy
Ryan Alexander JonesChief Financial Officer2024-05-2810,870$0.73
$7.94kBuy

1 of 1

KYTX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when KYTX insiders and whales buy or sell their stock.

KYTX Shareholders

What type of owners hold Kyverna Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vida Ventures LLC11.05%4,777,060$9.75MInsider
Fred E. Cohen10.47%4,523,924$9.23MInsider
Vida Ventures Advisors LLC10.47%4,523,924$9.23MInstitution
Gilead Sciences Inc9.55%4,126,119$8.42MInsider
Gilead Sciences Inc9.55%4,126,119$8.42MInstitution
Bain Capital Life Sciences Investors LLC7.79%3,368,370$6.87MInstitution
Northpond Ventures III GP LLC7.53%3,255,426$6.64MInsider
Bain Capital Life Sciences Investors LLC7.32%3,163,868$6.45MInsider
Jpmorgan Chase Co5.01%2,166,437$4.42MInstitution
Novo Holdings A4.28%1,850,000$3.77MInstitution

1 of 3

KYTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
KYTX56.40%43.60%Net Buying
VXRT15.67%54.65%Net SellingNet Selling
CSBR1.94%98.06%Net Buying
IFRX21.89%0.00%
ENTX16.54%16.18%Net BuyingNet Buying
View Top Biotech Stocks

Kyverna Therapeutics Stock Ownership FAQ

Who owns Kyverna Therapeutics?

Kyverna Therapeutics (NASDAQ: KYTX) is owned by 66.80% institutional shareholders, 51.65% Kyverna Therapeutics insiders, and 0.00% retail investors. Vida Ventures LLC is the largest individual Kyverna Therapeutics shareholder, owning 4.78M shares representing 11.05% of the company. Vida Ventures LLC's Kyverna Therapeutics shares are currently valued at $11.04M.

If you're new to stock investing, here's how to buy Kyverna Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.